Eye ultrasound could spot hidden artery disease
NCT ID NCT07001059
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 43 times
Summary
This study is testing whether measuring the optic nerve sheath with ultrasound can reliably diagnose giant cell arteritis (GCA), a condition that can cause blindness. Researchers will compare ultrasound measurements to the final diagnosis made by a specialist after 6 months. The study will enroll 190 people over 50 with suspected GCA.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS (GCA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Internal Medecine Department- CHU Caen
RECRUITINGCaen, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Internal Medicine and Clinical Immulogy department - Centre Hospitalier Universitaire de Dijon
NOT_YET_RECRUITINGDijon, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Internal Medicine and VascularMedecine Department - Centre Hospitalier Universitaire de Nantes
NOT_YET_RECRUITINGNantes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Internal Medicine department - Hôpital Saint-Antoine
NOT_YET_RECRUITINGParis, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rhumatology departement - Centre Hospitalier Aix en Provence
NOT_YET_RECRUITINGAix-en-Provence, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rhumatology department - Centre Hospitalier Universitaire de Brest
NOT_YET_RECRUITINGBrest, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rhumatology department - Centre Hospitalier Universitaire de Tours
NOT_YET_RECRUITINGTours, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rhumatology department - Hôpital Bichat
NOT_YET_RECRUITINGParis, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rhumatology department - Hôpital NOVO - Pontoise site
NOT_YET_RECRUITINGPontoise, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
orbital ultrasound
What this could lead to
If successful, this could provide a quick, non-invasive way to diagnose giant cell arteritis, potentially preventing vision loss.
What could go wrong
This is an early diagnostic study, not a treatment trial. The ultrasound measurement may not prove reliable enough to replace current diagnostic methods.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.